HCA Healthcare Inc. (NYSE: HCA) stock closed at 218.89 per share at the end of the most recent trading day (a 1.09% change compared to the prior day closing price) with a volume of 668.34K shares and market capitalization of 62.83B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 275000 people. HCA Healthcare Inc. CEO is Samuel N. Hazen.

The one-year performance of HCA Healthcare Inc. stock is -10.73%, while year-to-date (YTD) performance is -14.8%. HCA stock has a five-year performance of 175.78%. Its 52-week range is between 164.47 and 279.02, which gives HCA stock a 52-week price range ratio of 47.51%

HCA Healthcare Inc. currently has a PE ratio of 10.40, a price-to-book (PB) ratio of 292.01, a price-to-sale (PS) ratio of 1.03, a price to cashflow ratio of 8.70, a PEG ratio of 2.32, a ROA of 13.83%, a ROC of 5.19% and a ROE of -309.75%. The company’s profit margin is 12.10%, its EBITDA margin is 23.10%, and its revenue ttm is $60.10 Billion , which makes it $209.41 revenue per share.

Of the last four earnings reports from HCA Healthcare Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $3.67 for the next earnings report. HCA Healthcare Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for HCA Healthcare Inc. is Moderate Buy (1.6), with a target price of $239.1, which is +9.23% compared to the current price. The earnings rating for HCA Healthcare Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

HCA Healthcare Inc. has a dividend yield of 1.03% with a dividend per share of $2.24 and a payout ratio of 6.00%.

HCA Healthcare Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 15.29, ATR14 : 9.57, CCI20 : 84.39, Chaikin Money Flow : -0.12, MACD : 8.63, Money Flow Index : 71.63, ROC : 6.95, RSI : 86.33, STOCH (14,3) : 96.28, STOCH RSI : 0.51, UO : 50.55, Williams %R : -3.72), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of HCA Healthcare Inc. in the last 12-months were: Andrea B. Smith (Buy at a value of $247 815), Christopher F. Wyatt (Sold 2 100 shares of value $531 174 ), Deborah M. Reiner (Sold 2 052 shares of value $505 261 ), Jane D. Englebright (Option Excercise at a value of $534 931), Jane D. Englebright (Sold 3 364 shares of value $839 689 ), Jennifer Berres (Option Excercise at a value of $808 545), Jennifer L. Berres (Option Excercise at a value of $808 545), Jennifer L. Berres (Sold 2 358 shares of value $516 087 ), Jon M. Foster (Option Excercise at a value of $1 600 998), Jon M. Foster (Sold 16 294 shares of value $3 937 298 ), Joseph A. Sowell (Option Excercise at a value of $1 121 298), Joseph A. Sowell (Sold 33 720 shares of value $8 853 808 ), Kathleen M. Whalen (Option Excercise at a value of $504 300), Kathleen M. Whalen (Sold 4 315 shares of value $1 063 288 ), Kathryn A. Torres (Option Excercise at a value of $1 142 748), Michael R. McAlevey (Buy at a value of $242 602), Patricia F Elcan (Buy at a value of $64 565), Phillip G. Billington (Option Excercise at a value of $344 250), Phillip G. Billington (Sold 8 252 shares of value $2 032 096 ), Sammie S. Mosier (Option Excercise at a value of $0), Samuel N. Hazen (Option Excercise at a value of $0), Thomas F. Frist (Buy at a value of $37 766 000), William B. Rutherford (Sold 30 000 shares of value $7 500 000 )